211 related articles for article (PubMed ID: 21071332)
1. Biomarkers as prognostic factors in endometrial cancer.
Dobrzycka B; Terlikowski SJ
Folia Histochem Cytobiol; 2010 Sep; 48(3):319-22. PubMed ID: 21071332
[TBL] [Abstract][Full Text] [Related]
2. Biologic markers in endometrial cancer treatment.
Engelsen IB; Akslen LA; Salvesen HB
APMIS; 2009 Oct; 117(10):693-707. PubMed ID: 19775337
[TBL] [Abstract][Full Text] [Related]
3. Management of endometrial cancer.
Fowler W; Mutch D
Womens Health (Lond); 2008 Sep; 4(5):479-89. PubMed ID: 19072487
[TBL] [Abstract][Full Text] [Related]
4. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy of uterine clear cell carcinoma: a review.
Xu Y; Hanna RK; Elshaikh MA
Arch Gynecol Obstet; 2016 Mar; 293(3):485-92. PubMed ID: 26626183
[TBL] [Abstract][Full Text] [Related]
6. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
7. Update on prognostic markers for endometrial cancer.
Binder PS; Mutch DG
Womens Health (Lond); 2014 May; 10(3):277-88. PubMed ID: 24956294
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant treatment for stage IIIC endometrial cancer: options and controversies.
Shah PH; Kudrimoti M; Feddock J; Randall M
Gynecol Oncol; 2011 Sep; 122(3):675-83. PubMed ID: 21664661
[TBL] [Abstract][Full Text] [Related]
9. Current treatment options for endometrial cancer.
Santin AD; Bellone S; O'Brien TJ; Pecorelli S; Cannon MJ; Roman JJ
Expert Rev Anticancer Ther; 2004 Aug; 4(4):679-89. PubMed ID: 15270671
[TBL] [Abstract][Full Text] [Related]
10. [Adjuvant therapy and role of radiation therapy in advanced endometrial cancers].
Haie-Meder C; Paumier A; Lessard N; Morice P; Pautier P; Touboul C
Cancer Radiother; 2008 Nov; 12(6-7):630-2. PubMed ID: 18760653
[TBL] [Abstract][Full Text] [Related]
11. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
[TBL] [Abstract][Full Text] [Related]
12. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
[TBL] [Abstract][Full Text] [Related]
13. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
14. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
15. Advances in the management of endometrial adenocarcinoma. A review.
Irvin WP; Rice LW; Berkowitz RS
J Reprod Med; 2002 Mar; 47(3):173-89; discussion 189-90. PubMed ID: 11933681
[TBL] [Abstract][Full Text] [Related]
16. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
Ivanov I
Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
[TBL] [Abstract][Full Text] [Related]
17. [Effects of postoperative chemotherapy on the prognosis of patients with high-risk early stage endometrial cancer].
Wen HW; Tian F; Ma L; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2009 Mar; 44(3):196-9. PubMed ID: 19570445
[TBL] [Abstract][Full Text] [Related]
18. [Combined treatment and prognostic factors for stage III and IV endometrial carcinoma].
Ren YL; Wang HY; Shi DR; Yang WT; Sun Z; Chen Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):523-7. PubMed ID: 19080517
[TBL] [Abstract][Full Text] [Related]
19. Optimizing the management of stage II endometrial cancer: the role of radical hysterectomy and radiation.
Wright JD; Fiorelli J; Kansler AL; Burke WM; Schiff PB; Cohen CJ; Herzog TJ
Am J Obstet Gynecol; 2009 Apr; 200(4):419.e1-7. PubMed ID: 19136095
[TBL] [Abstract][Full Text] [Related]
20. The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma.
Jutzi L; Hoskins P; Lim P; Aquino-Parsons C; Tinker A; Kwon JS
Gynecol Oncol; 2013 Dec; 131(3):581-5. PubMed ID: 24055614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]